Clinical Trial Update: Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing two myeloablation regimens in pediatric high-risk neuroblastoma patients undergoing stem cell transplant; trial completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: Children's Oncology Group | Conditions: Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma | Phase 3 | Status: COMPLETED | Results posted: 2017-06-27